Substituted diazepan orexin receptor antagonists

Details for Australian Patent Application No. 2007272855 (hide)

Owner Merck & Co., Inc.

Inventors Cox, Christopher D.; Coleman, Paul J.; Breslin, Michael J.

Agent Spruson & Ferguson

Pub. Number AU-A-2007272855

PCT Pub. Number WO2008/008518

Priority 60/830,983 14.07.06 US

Filing date 13 July 2007

Wipo publication date 17 January 2008

International Classifications

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

5 February 2009 PCT application entered the National Phase

  PCT publication WO2008/008518 Priority application(s): WO2008/008518

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007272866-Stent

2007272854-Bridged diazepan orexin receptor antagonists